ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts (2006) 11 P640

Effects of long-term GH treatment in Prader-Willi adults

C Hoybye

Karolinska University Hospital, Stockholm, Sweden.

Objective: Prader-Willi syndrome (PWS) is a complex genetic disorder. Body composition abnormalities, hyperphagia, progressive obesity and diminished growth hormone secretion are common. In a previous one year GH intervention trial in 19 PWS adults, we have shown beneficial effects on body composition. In the present study we sought to re-evaluate the cohort, with special emphasis on long-term effects of GH treatment.

Methods: Fourteen patients, 7 men and 7 women, mean age 32 years, were evaluated. Mean follow-up was 6 years. Nine patients were treated with GH during a mean time of 5 years. Body composition and bone mineral density (BMD) were determined with Dual Energy X-ray absorptiometry (DEXA). Plasma glucose and serum insulin were measured

Results: Only small variations were seen in BMI, except in one woman (not treated with GH) who increased enormously in weight. In the GH treated patients a mean increase in lean body mass of 8 kg (P=0.004) and a mean decrease in body fat of 9% (P=0.017) were demonstrated. BMD was unchanged. Only one non-GH-treated woman developed overt diabetes.

Conclusion: In this cohort data show that five years of GH treatment has sustained favourable effects on body composition without significant side effects.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts